Smithfield Trust’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-690
Closed -$147K 845
2014
Q4
$147K Hold
690
0.03% 348
2014
Q3
$123K Buy
690
+20
+3% +$3.32K 0.02% 370
2014
Q2
$113K Sell
670
-225
-25% -$35K 0.02% 424
2014
Q1
$111K Hold
895
0.02% 431
2013
Q4
$99K Buy
895
+250
+39% +$23.9K 0.02% 435
2013
Q3
$58K Hold
645
0.01% 481
2013
Q2
$54K Buy
+645
New +$66.9K 0.01% 469

Other funds holding AGN

Smithfield Trust's AGN Position: Q1 2015 in Review

Smithfield Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 690 shares — an estimated $147K sold.

Smithfield Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $147K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Smithfield Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Smithfield Trust sold 690 Allergan Inc shares in Q1 2015, an estimated $147K.
  • Smithfield Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Smithfield Trust's Allergan Inc position peaked at $147K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Smithfield Trust's 13F filing for Q1 2015, filed 6 May 2015.